{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:59:14Z","timestamp":1792447154103,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bioadv.2022.213266","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:46:46Z","timestamp":1671731206000},"page":"213266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation"],"prefix":"10.1016","volume":"145","author":[{"given":"Humzah","family":"Jamshaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainat","family":"Nousheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul Majid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2022.213266_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1208\/s12249-022-02384-9","article-title":"Antileishmanial agents co-loaded in transfersomes with enhanced macrophage uptake and reduced toxicity","volume":"23","author":"Zahid","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2022.213266_bb0010","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.bioadv.2022.213266_bb0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"Van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioadv.2022.213266_bb0020","article-title":"Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis","volume":"79","author":"Khan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/1791-809X.1000519","article-title":"Leishmaniasis: a review on parasite, vector and reservoir host","volume":"11","author":"Alemayehu","year":"2017","journal-title":"Health Sci. J."},{"key":"10.1016\/j.bioadv.2022.213266_bb0030","doi-asserted-by":"crossref","DOI":"10.1017\/pao.2018.1","article-title":"Slow pace of antileishmanial drug development","volume":"4","author":"Kumar","year":"2018","journal-title":"Parasitol. Open"},{"key":"10.1016\/j.bioadv.2022.213266_bb0035","article-title":"Preparation, in-vitro and in-vivo evaluation of rifampicin and vancomycin co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis","volume":"60","author":"Salim","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2018.05.002","article-title":"Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes","volume":"185","author":"Nazari-Vanani","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioadv.2022.213266_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioadv.2022.213266_bb0050","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioadv.2022.213266_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/138955706776876131","article-title":"Topical imiquimod: mechanism of action and clinical applications","volume":"6","author":"Vidal","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioadv.2022.213266_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2006.12.004","article-title":"Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator imiquimod","volume":"116","author":"El-On","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0065","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioadv.2022.213266_bb0070","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioadv.2022.213266_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2018.05.007","article-title":"Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: in vitro and in silico studies","volume":"14","author":"Shokri","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bioadv.2022.213266_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00853-0","article-title":"Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight","volume":"19","author":"Jamshaid","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2016.07.043","article-title":"Mechanisms of imiquimod skin penetration","volume":"511","author":"Tel\u00f2","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2022.213266_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-18671-1","article-title":"A cutback in imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice","volume":"12","author":"Jamshaid","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2022.213266_bb0095","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nano-carriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0100","series-title":"Nanostructured Delivery Systems With Improved Leishmanicidal Activity: A Critical Review","first-page":"5289","volume":"12","author":"Bruni","year":"2017"},{"key":"10.1016\/j.bioadv.2022.213266_bb0105","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","author":"Martinez-Pomares","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10717540902989738","article-title":"Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches","volume":"16","author":"Pukanud","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2022.213266_bb0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.carbpol.2013.10.044","article-title":"Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis","volume":"101","author":"Chaubey","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2022.213266_bb0120","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2217\/nnm-2017-0248","article-title":"Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment","volume":"12","author":"Vieira","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0125","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2147\/IJN.S196771","article-title":"Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation","volume":"14","author":"Albash","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0130","article-title":"Statistically designed dexibuprofen loaded solid lipid nanoparticles for enhanced oral bioavailability","volume":"77","author":"Imran","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0135","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S86186","article-title":"Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes","volume":"10","author":"Ascenso","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40360-022-00625-y","article-title":"Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout","volume":"23","author":"Ali","year":"2022","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"ud Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/02652048.2020.1713242","article-title":"Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product","volume":"37","author":"Khaleeq","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.bioadv.2022.213266_bb0155","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/IJN.S299443","article-title":"Preparation, pharmacokinetics, and antitumor potential of miltefosine-loaded nanostructured lipid carriers","volume":"16","author":"Yu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0160","first-page":"16","article-title":"Development and validation of UV spectroscopy and RP-HPLC methods for estimation of imiquimod","volume":"35","author":"Jain","year":"2015","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.bioadv.2022.213266_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/2229-4708.90364","article-title":"Development and validation of the UV-spectrophotometric method for determination of terbinafine hydrochloride in bulk and in formulation","volume":"2","author":"Jain","year":"2011","journal-title":"Pharm.Methods"},{"key":"10.1016\/j.bioadv.2022.213266_bb0170","article-title":"Cilostazol-loaded solid lipid nanoparticles: bioavailability and safety evaluation in an animal model","volume":"74","author":"Bibi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112537","article-title":"Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects","volume":"216","author":"Gul","year":"2022","journal-title":"Colloids Surf.B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2022.213266_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2217\/nnm-2019-0320","article-title":"Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route","volume":"15","author":"Rabia","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0185","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.2147\/IJN.S274954","article-title":"Deformable liposomal hydrogel for dermal and transdermal delivery of meloxicam","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0190","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.xphs.2022.01.010","article-title":"Designing, optimization and characterization of Trifluralin transfersomal gel to passively target cutaneous leishmaniasis","volume":"111","author":"Khan","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2022.213266_bb0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/pharmaceutics12060523","article-title":"Development of a self-emulsifying drug delivery system for optimized topical delivery of clofazimine","volume":"12","author":"Van Staden","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2022.213266_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40005-018-00418-8","article-title":"E potential of nanoparticulate carriers for improved drug delivery via skin","volume":"49","author":"Zeb","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.bioadv.2022.213266_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2022.213266_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12249-012-9904-2","article-title":"Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers","volume":"14","author":"Duangjit","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2022.213266_bb0215","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.220428","article-title":"Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis","volume":"9","author":"Khalid","year":"2022","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.bioadv.2022.213266_bb0220","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10717544.2018.1494222","article-title":"Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell","volume":"25","author":"Dar","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2022.213266_bb0225","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1021\/acsnano.0c00364","article-title":"Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis","volume":"14","author":"Qindeel","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2022.213266_bb0230","first-page":"903","article-title":"In-vitro evaluation of antileishmanial activity and toxicity of artemether with focus on its apoptotic effect","volume":"12","author":"Ebrahimisadr","year":"2013","journal-title":"Iran. J Pharm. Res."},{"key":"10.1016\/j.bioadv.2022.213266_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171306","article-title":"Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B","volume":"12","author":"Shadab","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2022.213266_bb0240","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s11033-021-06313-0","article-title":"Association of cell free mitochondrial DNA and caspase-1 expression with disease severity and ARTs efficacy in HIV infection","volume":"48","author":"Ali","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioadv.2022.213266_bb0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","article-title":"Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice","volume":"196","author":"Kavian","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioadv.2022.213266_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69276-5","article-title":"Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis","volume":"10","author":"Parvez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2022.213266_bb0255","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/03639045.2021.1890768","article-title":"Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses","volume":"47","author":"Batool","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioadv.2022.213266_bb0260","doi-asserted-by":"crossref","first-page":"14808","DOI":"10.1039\/D2RA00742H","article-title":"Cisplatin and oleanolic acid co-loaded pH-sensitive CaCO3 nanoparticles for synergistic 2 chemotherapy","volume":"12","author":"Khan","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2022.213266_bb0265","unstructured":"B. Machler et al Imiquimod induced psoriasis: A case report, review of the literature, and pathophysiologic mechanism. MOSBY-ELSEVIER 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA."},{"key":"10.1016\/j.bioadv.2022.213266_bb0270","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3892\/ijmm.2017.2930","article-title":"Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice by inhibiting the maturation and activation of dendritic cells","volume":"39","author":"Meng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bioadv.2022.213266_bb0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/exd.13534","article-title":"Digital analysis yields more reliable and accurate measures of dermal and epidermal thickness in histologically processed specimens compared to traditional methods","volume":"27","author":"Turin","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121198","article-title":"Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects","volume":"311","author":"Maqsood","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bioadv.2022.213266_bb0285","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1007\/s00253-016-7422-y","article-title":"Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB\/c mice model","volume":"100","author":"Heidari-Kharaji","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0290","first-page":"1","article-title":"Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery","volume":"23","author":"Akram","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2022.213266_bb0295","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","article-title":"Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery","volume":"12","author":"Opatha","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2022.213266_bb0300","article-title":"Exploitation of the macrophage mannose receptor (CD206) in infectious disease diagnostics and therapeutics","volume":"1","author":"Azad","year":"2014","journal-title":"J. Cytol. Mol. Biol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jcma.2018.01.008","article-title":"Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs","volume":"81","author":"Yokota","year":"2018","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.bioadv.2022.213266_bb0310","doi-asserted-by":"crossref","DOI":"10.1063\/1.4962992","article-title":"Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry","volume":"10","author":"Clayton","year":"2016","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.bioadv.2022.213266_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120109","article-title":"Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of cutaneous leishmaniasis","volume":"593","author":"Khan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2022.213266_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1876402911666190603093550","article-title":"Formulation and characterization of transethosomes for enhanced transdermal delivery of propranolol hydrochloride","volume":"12","author":"Kumar","year":"2020","journal-title":"Micro Nanosyst."},{"key":"10.1016\/j.bioadv.2022.213266_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/nnm-2016-0325","article-title":"Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis","volume":"12","author":"Shahnaz","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0330","series-title":"Leishmania Promastigotes Lack Phosphatidylserine But Bind Annexin V Upon Permeabilization or Miltefosine Treatment","author":"Weing\u00e4rtner","year":"2012"},{"key":"10.1016\/j.bioadv.2022.213266_bb0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/ph15030331","article-title":"Carajurin induces apoptosis in Leishmania amazonensis promastigotes through reactive oxygen species production and mitochondrial dysfunction","volume":"15","author":"Silva-Silva","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioadv.2022.213266_bb0340","first-page":"1053","article-title":"Sesamol induces apoptosis-like cell death in Leishmania donovani","author":"Ali","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm-2017-0255","article-title":"Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis","volume":"13","author":"Sarwar","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0350","article-title":"Imiquimod induced psoriasis: a case report, review of the literature, and pathophysiologic mechanism: P3313","volume":"64","author":"Machler","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2022.213266_bb0355","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2147\/IJN.S170832","article-title":"Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles","volume":"13","author":"Sun","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213266_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006854","article-title":"EAPB0503: an imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica","volume":"12","author":"El Hajj","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioadv.2022.213266_bb0365","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/IAI.70.7.3727-3735.2002","article-title":"Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes","volume":"70","author":"Holzmuller","year":"2002","journal-title":"Infect. Immun."}],"updated-by":[{"DOI":"10.1016\/j.bioadv.2023.213350","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000}}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082200543X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082200543X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:49:40Z","timestamp":1699246180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277295082200543X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":73,"alternative-id":["S277295082200543X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2022.213266","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bioadv.2023.213350","asserted-by":"object"}]},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2022.213266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213266"}}